Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Blog
EndoTool SubQ: What You Should Know
Monarch Medical Technologies EndoTool SubQ provides clinical decision support for any situation where subcutaneous insulin is administered to all patient types, including pediatrics. This proprietary technology models, predicts and adjusts to each patient’s unique physiology and individual response to insulin.
- EndoTool will always recommend the safest, most effective patient-specific dose, beginning with the correct total daily dose and following with the precise recommended basal/bolus dose. How? EndoTool SubQ takes all factors that impact insulin response into account, including: blood glucose level, height, weight, type of diabetes mellitus, age, sex, creatinine levels, steroids, carbohydrate intake and ordered insulin.
- If a patient has low or consistently high readings, EndoTool will adjust accordingly, resulting in the reduction and elimination of correctional dosing.
- The software focuses on the most efficient and effective clinical workflow and promotes mealtime dosing in order to reduce cycling. If needed, EndoTool SubQ can accommodate another workflow, such as having to wait for the verification of carb intake.
- If at any time the nurse is concerned with the amount of insulin given due to a patient not eating as expected, the nurse may enter a new glucose. Based on the new glucose, EndoTool SubQ will recommend supplemental carbohydrates if needed.
- In the case of a patient receiving a low reading after a meal because they didn’t eat or is vomiting, EndoTool SubQ is the only platform where the algorithm will rapidly remodel and suggest additional carb recommendations prior to any hypoglycemic (BG <70 mg/dL) events.
EndoTool SubQ is changing the way we dose insulin in order to achieve better outcomes for our patients. This software provides caretakers the confidence in treating hyperglycemia while preventing hypoglycemia for an overall safer standard of care.
Related posts

Blog
New Data Reveals Safer Approach to DKA Treatment: Cutting ICU Stays in Half
New Data Reveals Safer Approach to DKA Treatment: Cutting ICU Stays in Half
Managing diabetic ketoacidosis (DKA) effectively is a growing challenge in hospitals nationwide. That's why our latest research, Improved Mortality, Length of Stay, and Cost of Care in Diabetic Ketoacidosis with the Use of a Computerized Insulin Dosing Algorithm, will be ...

Blog
Five Key Trends Impacting Hospitals in 2025
Five Key Trends Impacting Hospitals in 2025
As we navigate the evolving landscape of healthcare in 2025, I'm witnessing key trends that are shaping inpatient care. These shifts, fueled by advancements in technology, changing patient expectations, and workforce challenges, underscore the increasing importance of clinical decision support ...

Blog
A Year in Review: Advancing Patient-Specific Insulin Dosing for Better Outcomes
A Year in Review: Advancing Patient-Specific Insulin Dosing for Better Outcomes
CEO Quarterly Update As we close out the year 2024, I'd like to take a moment to reflect on the strides we've made in the patient-specific insulin dosing space. Our team has remained steadfast in our mission to improve the ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields